Systemic microvascular dysfunction in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study

17 May 2025 (09:20 - 09:30)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Jerremy Weerts

Maastricht University Medical Center+, Maastricht (Netherlands (The))

5 More presentations in this session

Presentation thumbnail

Body mass related epigenetic reprogramming and downstream analysis in heart failure phenotypes

Miss E. Yapici (Mainz, DE)

Abstract Slides Video

Presentation thumbnail

Long COVID: insights from echocardiography, cardiac magnetic resonance, and endomyocardial Biopsies in previous healthy individuals with persistent chest pain

Doctor O. Gomez Monterrosas (Puebla, MX)

Abstract Slides Video

Presentation thumbnail

A characterisation of mitochondrial structure, oxidative phosphorylation capacity, and amyloid burden in patients with wild-type transthyretin cardiomyopathy

Doctor B. Ladefoged (Aarhus, DK)

Abstract Slides Video

Presentation thumbnail

Beneficial metabolic effects of 2-week ketone ester in patients with type 2 diabetes and heart failure with preserved ejection fraction.

Doctor N. Gopalasingam (Herning, DK)

Abstract Slides Video

Presentation thumbnail

The effect of spironolactone on infections in heart failure with preserved ejection fraction

Doctor B. Szabo-Soderberg (Stockholm, SE)

Abstract Slides Video

Access the full session

Session thumbnail

Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

The Event

Event poster

Heart Failure 2025

17 May 2025 09:20 CET

You may be interested in

Congress Session

Refining phenotyping in heart failure

Congress Session

Insights from recent HFpEF trials 1

Congress Session

Young Investigator Award (YIA) Clinical Cardiology

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources